BRIEF-CA Healthcare Acquisition Corp Says LumiraDx To List On Nasdaq Via Merger With Co

Reuters

Apr 07, 2021

April 7 (Reuters) - Ca Healthcare Acquisition Corp :

* LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS TESTING COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE ACQUISITION CORP

* COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION

* LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER

* NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH

* LUMIRADX SECURED $400 MILLION IN NEW DEBT FINANCING

* LUMIRADX ESTIMATES 2021 REVENUE OF $600 MILLION - $1 BILLION

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2125717044"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2125717044\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2125717044?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-07 13:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2125717044","market":"us","top_or_hot":-1,"title":"BRIEF-CA Healthcare Acquisition Corp Says LumiraDx To List On Nasdaq Via Merger With Co","media":"Reuters","content":"<html><body><p>April 7 (Reuters) - Ca Healthcare Acquisition Corp   :</p><p>   * LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS TESTING COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE ACQUISITION CORP</p><p>   * COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION</p><p>   * LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER</p><p>   * NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH</p><p>   * LUMIRADX SECURED $400 MILLION IN NEW DEBT FINANCING</p><p>   * LUMIRADX ESTIMATES 2021 REVENUE OF $600 MILLION - $1 BILLION</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-CA Healthcare Acquisition Corp Says LumiraDx To List On Nasdaq Via Merger With Co</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-CA Healthcare Acquisition Corp Says LumiraDx To List On Nasdaq Via Merger With Co\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-07 13:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>April 7 (Reuters) - Ca Healthcare Acquisition Corp   :</p><p>   * LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS TESTING COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE ACQUISITION CORP</p><p>   * COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION</p><p>   * LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER</p><p>   * NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH</p><p>   * LUMIRADX SECURED $400 MILLION IN NEW DEBT FINANCING</p><p>   * LUMIRADX ESTIMATES 2021 REVENUE OF $600 MILLION - $1 BILLION</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAHCU","symbol_name":"CA Healthcare Acquisition Corp","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2125717044","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2125717044","pubTimestamp":1617772420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 7  - Ca Healthcare Acquisition Corp   :   * LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS TESTING COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE ACQUISITION CORP   * COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION   * LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER   * NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH   * LUMIRADX SECURED $400 MIL","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAHCU":"CA Healthcare Acquisition Corp"},"translate_title":"简讯-CA Healthcare Acquisition Corp称LumiraDx将通过与Co合并在纳斯达克上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NQmain":1,"CAHC":1,"CAHCU":1},"content_text":"April 7 (Reuters) - Ca Healthcare Acquisition Corp   :   * LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS TESTING COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE ACQUISITION CORP   * COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION   * LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER   * NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH   * LUMIRADX SECURED $400 MILLION IN NEW DEBT FINANCING   * LUMIRADX ESTIMATES 2021 REVENUE OF $600 MILLION - $1 BILLIONSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}